CLAIMBOUND / SOURCE-PUBLICATION EVIDENCE

Pharmaceuticals

70 distinct source statements, not 70 independently proven facts. 70 results use an official primary source; 0 retain their explicitly limited Wikidata publication boundary.

Every card identifies what it proves, what it does not prove, its exact quote, locator, source hash, and local rerun command.

70 / 70primary-source statements
0 / 70independent ClaimBound reruns
CB7K-DOM018-C01registry slot CB7K-DOM018-T01-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

1. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 3

Narrow public claim

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has the mission of achieving greater regulatory harmonization worldwide to ensure that safe, effective, and high-quality medicines are developed, registered, and maintained in the most resource-efficient manner.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 3
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has the mission of achieving greater regulatory harmonization worldwide to ensure that safe, effective, and high-quality medicines are developed, registered, and maintained in the most resource-efficient manner.
CB7K-DOM018-C02registry slot CB7K-DOM018-T01-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

2. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 3

Narrow public claim

By harmonizing the regulatory expectations in regions around the world, ICH guidelines have substantially reduced duplicative clinical studies, prevented unnecessary animal studies, standardized safety reporting and marketing application submissions, and contributed to many other improvements in the quality of global drug development and manufacturing and the products available to patients.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 3
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
By harmonizing the regulatory expectations in regions around the world, ICH guidelines have substantially reduced duplicative clinical studies, prevented unnecessary animal studies, standardized safety reporting and marketing application submissions, and contributed to many other improvements in the quality of global drug development and manufacturing and the products available to patients.
CB7K-DOM018-C03registry slot CB7K-DOM018-T01-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

3. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 3

Narrow public claim

ICH is a consensus-driven process that involves technical experts from regulatory authorities and industry parties in detailed technical and science-based harmonization work that results in the development of ICH guidelines.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 3
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
ICH is a consensus-driven process that involves technical experts from regulatory authorities and industry parties in detailed technical and science-based harmonization work that results in the development of ICH guidelines.
CB7K-DOM018-C04registry slot CB7K-DOM018-T01-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

4. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6

Narrow public claim

Risk management principles are effectively utilized in many areas of business and government including finance, insurance, occupational safety, public health, pharmacovigilance, and by agencies regulating these industries.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 6
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Risk management principles are effectively utilized in many areas of business and government including finance, insurance, occupational safety, public health, pharmacovigilance, and by agencies regulating these industries.
CB7K-DOM018-C05registry slot CB7K-DOM018-T01-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

5. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6

Narrow public claim

In the pharmaceutical sector, the principles and framework of ICH Q9, coupled with the official ICH training material that supports this guideline, are instrumental in enhancing the application of effective quality risk management by industry and regulators.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 6
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In the pharmaceutical sector, the principles and framework of ICH Q9, coupled with the official ICH training material that supports this guideline, are instrumental in enhancing the application of effective quality risk management by industry and regulators.
CB7K-DOM018-C06registry slot CB7K-DOM018-T01-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

6. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6

Narrow public claim

The importance of quality systems has been recognized in the pharmaceutical industry and it is evident that quality risk management is a valuable component of an effective quality system.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 6
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The importance of quality systems has been recognized in the pharmaceutical industry and it is evident that quality risk management is a valuable component of an effective quality system.
CB7K-DOM018-C07registry slot CB7K-DOM018-T01-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

7. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 6

Narrow public claim

It is commonly understood that risk is defined as the combination of the probability of occurrence of harm and the severity of that harm.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 6
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
It is commonly understood that risk is defined as the combination of the probability of occurrence of harm and the severity of that harm.
CB7K-DOM018-C08registry slot CB7K-DOM018-T01-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

8. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7

Narrow public claim

An effective quality risk management approach can further ensure the quality of the drug (medicinal) product to the patient by providing a proactive means to identify and control potential quality issues during development, manufacturing, and distribution.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 7
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
An effective quality risk management approach can further ensure the quality of the drug (medicinal) product to the patient by providing a proactive means to identify and control potential quality issues during development, manufacturing, and distribution.
CB7K-DOM018-C09registry slot CB7K-DOM018-T01-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

9. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7

Narrow public claim

This includes an appropriate application of root cause analysis that can identify and address the root cause(s) and other causal factors (e.g., human-related) of such issues.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 7
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
This includes an appropriate application of root cause analysis that can identify and address the root cause(s) and other causal factors (e.g., human-related) of such issues.
CB7K-DOM018-C10registry slot CB7K-DOM018-T01-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

10. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7

Narrow public claim

A proactive approach to quality risk management is beneficial, as it facilitates robust product design and continual improvement, and it is of strategic importance in achieving an effective pharmaceutical quality system (see the International Council for Harmonisation (ICH) guidance for industry Q10 Pharmaceutical Quality System (ICH Q10) (April 2009)3 for guidance in relation to an effective pharmaceutical quality system).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 7
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t01_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
A proactive approach to quality risk management is beneficial, as it facilitates robust product design and continual improvement, and it is of strategic importance in achieving an effective pharmaceutical quality system (see the International Council for Harmonisation (ICH) guidance for industry Q10 Pharmaceutical Quality System (ICH Q10) (April 2009)3 for guidance in relation to an effective pharmaceutical quality system).
CB7K-DOM018-C11registry slot CB7K-DOM018-T02-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

11. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 7

Narrow public claim

In the development phase and as part of validation, quality risk management is part of building knowledge and understanding risk scenarios, so that appropriate risk control can be decided upon for use during the commercial manufacturing phase.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 7
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In the development phase and as part of validation, quality risk management is part of building knowledge and understanding risk scenarios, so that appropriate risk control can be decided upon for use during the commercial manufacturing phase.
CB7K-DOM018-C12registry slot CB7K-DOM018-T02-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

12. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8

Narrow public claim

An understanding of formality can also support risk-based decision-making, where the level of formality that is applied may reflect the degree of importance of the decision, as well as the level of uncertainty and complexity which may be present.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 8
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
An understanding of formality can also support risk-based decision-making, where the level of formality that is applied may reflect the degree of importance of the decision, as well as the level of uncertainty and complexity which may be present.
CB7K-DOM018-C13registry slot CB7K-DOM018-T02-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

13. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8

Narrow public claim

Appropriate use of quality risk management can facilitate but does not obviate industry’s obligation to comply with regulatory requirements and does not replace appropriate communications between industry and regulators.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 8
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Appropriate use of quality risk management can facilitate but does not obviate industry’s obligation to comply with regulatory requirements and does not replace appropriate communications between industry and regulators.
CB7K-DOM018-C14registry slot CB7K-DOM018-T02-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

14. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8

Narrow public claim

Quality risk management should not be used in a manner where decisions are made that justify a practice that would otherwise, in accordance with regulations and/or guidance, be deemed unacceptable.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 8
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Quality risk management should not be used in a manner where decisions are made that justify a practice that would otherwise, in accordance with regulations and/or guidance, be deemed unacceptable.
CB7K-DOM018-C15registry slot CB7K-DOM018-T02-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

15. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 8

Narrow public claim

Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 8
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Instead, guidances describe the Agency’s current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.
CB7K-DOM018-C16registry slot CB7K-DOM018-T02-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

16. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 9

Narrow public claim

These decisions might be to return to the previous step and seek further information, to adjust the risk models or even to terminate the risk management process based upon information that supports such a decision.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 9
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
These decisions might be to return to the previous step and seek further information, to adjust the risk models or even to terminate the risk management process based upon information that supports such a decision.
CB7K-DOM018-C17registry slot CB7K-DOM018-T02-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

17. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 9

Narrow public claim

Responsibilities (4.1) Quality risk management activities are usually, but not always, undertaken by interdisciplinary teams.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 9
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Responsibilities (4.1) Quality risk management activities are usually, but not always, undertaken by interdisciplinary teams.
CB7K-DOM018-C18registry slot CB7K-DOM018-T02-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

18. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 9

Narrow public claim

When teams are formed, they should include experts from the appropriate areas (e.g., quality unit, product development, business development, engineering, regulatory affairs, production operations, sales and marketing, supply chain, legal, statistics and clinical) in addition to individuals who are knowledgeable about the quality risk management process.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 9
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
When teams are formed, they should include experts from the appropriate areas (e.g., quality unit, product development, business development, engineering, regulatory affairs, production operations, sales and marketing, supply chain, legal, statistics and clinical) in addition to individuals who are knowledgeable about the quality risk management process.
CB7K-DOM018-C19registry slot CB7K-DOM018-T02-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

19. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 10

Narrow public claim

Initiating a Quality Risk Management Process (4.2) Quality risk management should include systematic processes designed to coordinate, facilitate and improve science-based decision-making with respect to risk.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 10
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Initiating a Quality Risk Management Process (4.2) Quality risk management should include systematic processes designed to coordinate, facilitate and improve science-based decision-making with respect to risk.
CB7K-DOM018-C20registry slot CB7K-DOM018-T02-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

20. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 10

Narrow public claim

When the risk in question is well defined, an appropriate risk management tool (see examples in section V (5)) and the types of information needed to address the risk question will be more readily identifiable.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 10
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t02_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
When the risk in question is well defined, an appropriate risk management tool (see examples in section V (5)) and the types of information needed to address the risk question will be more readily identifiable.
CB7K-DOM018-C21registry slot CB7K-DOM018-T03-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

21. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 10

Narrow public claim

Hazard identification is a systematic use of information to identify hazards referring to the risk question or problem description.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 10
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Hazard identification is a systematic use of information to identify hazards referring to the risk question or problem description.
CB7K-DOM018-C22registry slot CB7K-DOM018-T03-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

22. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11

Narrow public claim

In doing an effective risk assessment, the robustness of the data set is important because it determines the quality of the output.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 11
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
In doing an effective risk assessment, the robustness of the data set is important because it determines the quality of the output.
CB7K-DOM018-C23registry slot CB7K-DOM018-T03-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

23. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11

Narrow public claim

Revealing assumptions and reasonable sources of uncertainty will enhance confidence in this output and/or help identify its limitations.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 11
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Revealing assumptions and reasonable sources of uncertainty will enhance confidence in this output and/or help identify its limitations.
CB7K-DOM018-C24registry slot CB7K-DOM018-T03-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

24. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11

Narrow public claim

The output of a risk assessment is either a quantitative estimate of risk or a qualitative description of a range of risk.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 11
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The output of a risk assessment is either a quantitative estimate of risk or a qualitative description of a range of risk.
CB7K-DOM018-C25registry slot CB7K-DOM018-T03-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

25. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 11

Narrow public claim

Alternatively, risk can be expressed using qualitative descriptors, such as “high,” “medium,” or “low,” which should be defined in as much detail as possible.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 11
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Alternatively, risk can be expressed using qualitative descriptors, such as “high,” “medium,” or “low,” which should be defined in as much detail as possible.
CB7K-DOM018-C26registry slot CB7K-DOM018-T03-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

26. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12

Narrow public claim

Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control strategy.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 12
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Processes that improve the detectability of hazards and quality risks might also be used as part of a risk control strategy.
CB7K-DOM018-C27registry slot CB7K-DOM018-T03-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

27. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12

Narrow public claim

The implementation of risk reduction measures can introduce new risks into the system or increase the significance of other existing risks.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 12
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The implementation of risk reduction measures can introduce new risks into the system or increase the significance of other existing risks.
CB7K-DOM018-C28registry slot CB7K-DOM018-T03-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

28. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12

Narrow public claim

Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk after implementing a risk reduction process.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 12
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Hence, it might be appropriate to revisit the risk assessment to identify and evaluate any possible change in risk after implementing a risk reduction process.
CB7K-DOM018-C29registry slot CB7K-DOM018-T03-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

29. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 12

Narrow public claim

Risk Communication (4.5) Risk communication is the sharing of information about risk and risk management between the decision makers and others.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 12
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Risk Communication (4.5) Risk communication is the sharing of information about risk and risk management between the decision makers and others.
CB7K-DOM018-C30registry slot CB7K-DOM018-T03-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

30. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13

Narrow public claim

While detectability may not be a discrete factor in some quality risk management methods, detection controls are important as they can reduce the probability of occurrence of harm.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 13
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t03_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
While detectability may not be a discrete factor in some quality risk management methods, detection controls are important as they can reduce the probability of occurrence of harm.
CB7K-DOM018-C31registry slot CB7K-DOM018-T04-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

31. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13

Narrow public claim

Traditionally, risks to quality have been assessed and managed in a variety of ways (empirical and/or internal procedures) based on, for example, compilation of observations, trends, and other information.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 13
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Traditionally, risks to quality have been assessed and managed in a variety of ways (empirical and/or internal procedures) based on, for example, compilation of observations, trends, and other information.
CB7K-DOM018-C32registry slot CB7K-DOM018-T04-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

32. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13

Narrow public claim

Such approaches continue to provide useful information that might support topics such as handling of complaints, quality defects, deviations, and allocation of resources.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 13
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Such approaches continue to provide useful information that might support topics such as handling of complaints, quality defects, deviations, and allocation of resources.
CB7K-DOM018-C33registry slot CB7K-DOM018-T04-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

33. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 13

Narrow public claim

Formality in Quality Risk Management (5.1) Formality in quality risk management is not a binary concept (i.e., formal/informal); varying degrees of formality may be applied during quality risk management activities, including when making risk-based decisions.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 13
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Formality in Quality Risk Management (5.1) Formality in quality risk management is not a binary concept (i.e., formal/informal); varying degrees of formality may be applied during quality risk management activities, including when making risk-based decisions.
CB7K-DOM018-C34registry slot CB7K-DOM018-T04-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

34. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14

Narrow public claim

Systematic approaches for acquiring, analyzing, storing, and disseminating scientific information are essential for generating knowledge, which in turn informs all quality risk management activities.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 14
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Systematic approaches for acquiring, analyzing, storing, and disseminating scientific information are essential for generating knowledge, which in turn informs all quality risk management activities.
CB7K-DOM018-C35registry slot CB7K-DOM018-T04-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

35. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14

Narrow public claim

Uncertainty may be reduced via effective knowledge management, which enables accumulated and new information (both internal and external) to be used to support risk-based decisions throughout the product lifecycle.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 14
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Uncertainty may be reduced via effective knowledge management, which enables accumulated and new information (both internal and external) to be used to support risk-based decisions throughout the product lifecycle.
CB7K-DOM018-C36registry slot CB7K-DOM018-T04-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

36. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14

Narrow public claim

Importance: The more important a risk-based decision may be in relation to product quality, the higher the level of formality that should be applied, and the greater the need to reduce the level of uncertainty associated with it.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 14
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Importance: The more important a risk-based decision may be in relation to product quality, the higher the level of formality that should be applied, and the greater the need to reduce the level of uncertainty associated with it.
CB7K-DOM018-C37registry slot CB7K-DOM018-T04-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

37. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 14

Narrow public claim

Complexity: The more complex a process or subject area is to a quality risk management activity, the higher the level of formality that should be applied to assure product quality.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 14
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Complexity: The more complex a process or subject area is to a quality risk management activity, the higher the level of formality that should be applied to assure product quality.
CB7K-DOM018-C38registry slot CB7K-DOM018-T04-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

38. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15

Narrow public claim

Risk-Based Decision-Making (5.2) Risk-based decision-making is inherent in all quality risk management activities; it provides an essential foundation for decision makers in an organization.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 15
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Risk-Based Decision-Making (5.2) Risk-based decision-making is inherent in all quality risk management activities; it provides an essential foundation for decision makers in an organization.
CB7K-DOM018-C39registry slot CB7K-DOM018-T04-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

39. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15

Narrow public claim

Effective risk-based decisionmaking begins with determining the level of effort, formality and documentation that should be applied during the quality risk management process.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 15
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Effective risk-based decisionmaking begins with determining the level of effort, formality and documentation that should be applied during the quality risk management process.
CB7K-DOM018-C40registry slot CB7K-DOM018-T04-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

40. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15

Narrow public claim

The decisions made from quality risk management activities include those in relation to what hazards exist, the risks associated with those hazards, the risk controls required, the acceptability of the residual risk after risk controls, and the communication and review of quality risk management activities and outputs.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 15
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t04_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The decisions made from quality risk management activities include those in relation to what hazards exist, the risks associated with those hazards, the risk controls required, the acceptability of the residual risk after risk controls, and the communication and review of quality risk management activities and outputs.
CB7K-DOM018-C41registry slot CB7K-DOM018-T05-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

41. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 15

Narrow public claim

(See section V.A (5.1) above for guidance on what constitutes formality in quality risk management.) Higher levels of formality in quality risk management may require higher levels of structure in relation to risk-based decision-making.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 15
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
(See section V.A (5.1) above for guidance on what constitutes formality in quality risk management.) Higher levels of formality in quality risk management may require higher levels of structure in relation to risk-based decision-making.
CB7K-DOM018-C42registry slot CB7K-DOM018-T05-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

42. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 16

Narrow public claim

Managing and Minimizing Subjectivity (5.3) Subjectivity can impact every stage of a quality risk management process, especially the identification of hazards and the estimation of probability of occurrence and severity of harm.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 16
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Managing and Minimizing Subjectivity (5.3) Subjectivity can impact every stage of a quality risk management process, especially the identification of hazards and the estimation of probability of occurrence and severity of harm.
CB7K-DOM018-C43registry slot CB7K-DOM018-T05-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

43. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 16

Narrow public claim

While subjectivity cannot be completely eliminated from quality risk management activities, it may be controlled by addressing bias and assumptions, the proper use of quality risk management tools and maximizing the use of relevant data and sources of knowledge (see ICH Q10, section II.E.1 (1.6.1)).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 16
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
While subjectivity cannot be completely eliminated from quality risk management activities, it may be controlled by addressing bias and assumptions, the proper use of quality risk management tools and maximizing the use of relevant data and sources of knowledge (see ICH Q10, section II.E.1 (1.6.1)).
CB7K-DOM018-C44registry slot CB7K-DOM018-T05-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

44. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 17

Narrow public claim

Training of both industry and regulatory personnel in quality risk management processes provides for greater understanding of decision-making processes and builds confidence in quality risk management outcomes.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 17
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Training of both industry and regulatory personnel in quality risk management processes provides for greater understanding of decision-making processes and builds confidence in quality risk management outcomes.
CB7K-DOM018-C45registry slot CB7K-DOM018-T05-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

45. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 17

Narrow public claim

The Role of Quality Risk Management in Addressing Product Availability Risks Arising From Quality/Manufacturing Issues (6.1) Quality/manufacturing issues, including non-compliance with Good Manufacturing Practice (GMP), are a significant cause of product availability issues (e.g., product shortages).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 17
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The Role of Quality Risk Management in Addressing Product Availability Risks Arising From Quality/Manufacturing Issues (6.1) Quality/manufacturing issues, including non-compliance with Good Manufacturing Practice (GMP), are a significant cause of product availability issues (e.g., product shortages).
CB7K-DOM018-C46registry slot CB7K-DOM018-T05-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

46. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 18

Narrow public claim

When risk-based drug shortage prevention and mitigation activities are performed, the level of formality that is applied to those activities may vary (see section V.A (5.1)) and should be commensurate with the level of risk associated with a loss of availability of the product(s).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 18
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
When risk-based drug shortage prevention and mitigation activities are performed, the level of formality that is applied to those activities may vary (see section V.A (5.1)) and should be commensurate with the level of risk associated with a loss of availability of the product(s).
CB7K-DOM018-C47registry slot CB7K-DOM018-T05-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

47. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 18

Narrow public claim

A successful manufacturing partnership is strengthened by appropriate communication and collaboration mechanisms (See section II.G (2.7) of ICH Q10).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 18
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
A successful manufacturing partnership is strengthened by appropriate communication and collaboration mechanisms (See section II.G (2.7) of ICH Q10).
CB7K-DOM018-C48registry slot CB7K-DOM018-T05-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

48. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 20

Narrow public claim

Hazard Identification: The systematic use of information to identify potential sources of harm (hazards) referring to the risk question or problem description.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 20
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Hazard Identification: The systematic use of information to identify potential sources of harm (hazards) referring to the risk question or problem description.
CB7K-DOM018-C49registry slot CB7K-DOM018-T05-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

49. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 20

Narrow public claim

Quality System: The sum of all aspects of a system that implements quality policy and ensures that quality objectives are met.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 20
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Quality System: The sum of all aspects of a system that implements quality policy and ensures that quality objectives are met.
CB7K-DOM018-C50registry slot CB7K-DOM018-T05-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

50. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 21

Narrow public claim

Stakeholder: Any individual, group or organization that can affect, be affected by, or perceive itself to be affected by a risk.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 21
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t05_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Stakeholder: Any individual, group or organization that can affect, be affected by, or perceive itself to be affected by a risk.
CB7K-DOM018-C51registry slot CB7K-DOM018-T06-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

51. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 21

Narrow public claim

For the purposes of this guideline, the primary stakeholders are the patient, healthcare professional, regulatory authority, and industry.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 21
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
For the purposes of this guideline, the primary stakeholders are the patient, healthcare professional, regulatory authority, and industry.
CB7K-DOM018-C52registry slot CB7K-DOM018-T06-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

52. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 24

Narrow public claim

Failure Mode Effects Analysis (FMEA) (I.2) FMEA (see IEC 60812) provides for an evaluation of potential failure modes for processes and their likely effect on outcomes and/or product performance.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 24
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Failure Mode Effects Analysis (FMEA) (I.2) FMEA (see IEC 60812) provides for an evaluation of potential failure modes for processes and their likely effect on outcomes and/or product performance.
CB7K-DOM018-C53registry slot CB7K-DOM018-T06-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

53. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 24

Narrow public claim

Failure Mode, Effects, and Criticality Analysis (FMECA) (I.3) FMEA might be extended to incorporate an investigation of the degree of severity of the consequences, their respective probabilities of occurrence, and their detectability, thereby becoming a Failure Mode Effect and Criticality Analysis (FMECA; see IEC 60812).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 24
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Failure Mode, Effects, and Criticality Analysis (FMECA) (I.3) FMEA might be extended to incorporate an investigation of the degree of severity of the consequences, their respective probabilities of occurrence, and their detectability, thereby becoming a Failure Mode Effect and Criticality Analysis (FMECA; see IEC 60812).
CB7K-DOM018-C54registry slot CB7K-DOM018-T06-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

54. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 25

Narrow public claim

Fault Tree Analysis (FTA) (I.4) The FTA tool (see IEC 61025) is an approach that assumes failure of the functionality of a product or process.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 25
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Fault Tree Analysis (FTA) (I.4) The FTA tool (see IEC 61025) is an approach that assumes failure of the functionality of a product or process.
CB7K-DOM018-C55registry slot CB7K-DOM018-T06-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

55. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 25

Narrow public claim

Hazard Analysis and Critical Control Points (HACCP) (I.5) HACCP is a systematic, proactive, and preventive tool for assuring product quality, reliability, and safety (see WHO Technical Report Series No 908, 2003 Annex 7).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 25
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Hazard Analysis and Critical Control Points (HACCP) (I.5) HACCP is a systematic, proactive, and preventive tool for assuring product quality, reliability, and safety (see WHO Technical Report Series No 908, 2003 Annex 7).
CB7K-DOM018-C56registry slot CB7K-DOM018-T06-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

56. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 26

Narrow public claim

Hazard Operability Analysis (HAZOP) (I.6) HAZOP (see IEC 61882) is based on a theory that assumes that risk events are caused by deviations from the design or operating intentions.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 26
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Hazard Operability Analysis (HAZOP) (I.6) HAZOP (see IEC 61882) is based on a theory that assumes that risk events are caused by deviations from the design or operating intentions.
CB7K-DOM018-C57registry slot CB7K-DOM018-T06-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

57. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 26

Narrow public claim

Preliminary Hazard Analysis (PHA) (I.7) PHA is a tool of analysis based on applying prior experience or knowledge of a hazard or failure to identify future hazards, hazardous situations and events that might cause harm, as well as to estimate their probability of occurrence for a given activity, facility, product, or system.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 26
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Preliminary Hazard Analysis (PHA) (I.7) PHA is a tool of analysis based on applying prior experience or knowledge of a hazard or failure to identify future hazards, hazardous situations and events that might cause harm, as well as to estimate their probability of occurrence for a given activity, facility, product, or system.
CB7K-DOM018-C58registry slot CB7K-DOM018-T06-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

58. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 26

Narrow public claim

The tool consists of: (1) the identification of the possibilities that the risk event happens; (2) the qualitative evaluation of the extent of possible injury or damage to health that could result; (3) a relative ranking of the hazard using a combination of severity and likelihood of occurrence; and (4) the identification of possible remedial measures.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 26
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
The tool consists of: (1) the identification of the possibilities that the risk event happens; (2) the qualitative evaluation of the extent of possible injury or damage to health that could result; (3) a relative ranking of the hazard using a combination of severity and likelihood of occurrence; and (4) the identification of possible remedial measures.
CB7K-DOM018-C59registry slot CB7K-DOM018-T06-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

59. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 27

Narrow public claim

It can be used for product, process, and facility design as well as to evaluate the types of hazards for the general product type, then the product class, and finally the specific product.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 27
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
It can be used for product, process, and facility design as well as to evaluate the types of hazards for the general product type, then the product class, and finally the specific product.
CB7K-DOM018-C60registry slot CB7K-DOM018-T06-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

60. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 27

Narrow public claim

Typically, hazards identified in the PHA are further assessed with other risk management tools such as those in this section.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 27
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t06_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Typically, hazards identified in the PHA are further assessed with other risk management tools such as those in this section.
CB7K-DOM018-C61registry slot CB7K-DOM018-T07-G01PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

61. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 28

Narrow public claim

This Annex is intended to identify potential uses of quality risk management principles and tools by industry and regulators.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 28
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
This Annex is intended to identify potential uses of quality risk management principles and tools by industry and regulators.
CB7K-DOM018-C62registry slot CB7K-DOM018-T07-G02PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

62. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 28

Narrow public claim

However, the selection of particular risk management tools is completely dependent upon specific facts and circumstances.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 28
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
However, the selection of particular risk management tools is completely dependent upon specific facts and circumstances.
CB7K-DOM018-C63registry slot CB7K-DOM018-T07-G03PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

63. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 29

Narrow public claim

Change Management/Change Control To manage changes based on knowledge and information accumulated in pharmaceutical development and during manufacturing; To evaluate the impact of the changes on the availability of the final product; To evaluate the impact on product quality of changes to the facility, equipment, material, manufacturing process or technical transfers; To determine appropriate actions preceding the implementation of a change, e.g., additional testing, (re)qualification, (re)validation or communication with regulators.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 29
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Change Management/Change Control To manage changes based on knowledge and information accumulated in pharmaceutical development and during manufacturing; To evaluate the impact of the changes on the availability of the final product; To evaluate the impact on product quality of changes to the facility, equipment, material, manufacturing process or technical transfers; To determine appropriate actions preceding the implementation of a change, e.g., additional testing, (re)qualification, (re)validation or communication with regulators.
CB7K-DOM018-C64registry slot CB7K-DOM018-T07-G04PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

64. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 31

Narrow public claim

Hygiene Aspects in Facilities To protect the product from environmental hazards, including chemical, microbiological, and physical hazards (e.g., determining appropriate clothing and gowning, hygiene concerns); To protect the environment (e.g., personnel, potential for cross-contamination) from hazards related to the product being manufactured.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 31
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Hygiene Aspects in Facilities To protect the product from environmental hazards, including chemical, microbiological, and physical hazards (e.g., determining appropriate clothing and gowning, hygiene concerns); To protect the environment (e.g., personnel, potential for cross-contamination) from hazards related to the product being manufactured.
CB7K-DOM018-C65registry slot CB7K-DOM018-T07-G05PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

65. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 32

Narrow public claim

Quality Risk Management as Part of Materials Management Assessment and Evaluation of Suppliers and Contract Manufacturers (II.5) To provide a comprehensive evaluation of suppliers and contract manufacturers (e.g., auditing, supplier quality agreements).

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 32
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Quality Risk Management as Part of Materials Management Assessment and Evaluation of Suppliers and Contract Manufacturers (II.5) To provide a comprehensive evaluation of suppliers and contract manufacturers (e.g., auditing, supplier quality agreements).
CB7K-DOM018-C66registry slot CB7K-DOM018-T07-G06PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

66. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 32

Narrow public claim

Quality Risk Management as Part of Production Validation (II.6) To identify the scope and extent of verification, qualification, and validation activities (e.g., analytical methods, processes, equipment, and cleaning methods); To determine the extent for follow-up activities (e.g., sampling, monitoring and re-validation); To distinguish between critical and non-critical process steps to facilitate design of a validation study.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 32
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Quality Risk Management as Part of Production Validation (II.6) To identify the scope and extent of verification, qualification, and validation activities (e.g., analytical methods, processes, equipment, and cleaning methods); To determine the extent for follow-up activities (e.g., sampling, monitoring and re-validation); To distinguish between critical and non-critical process steps to facilitate design of a validation study.
CB7K-DOM018-C67registry slot CB7K-DOM018-T07-G07PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

67. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 33

Narrow public claim

Quality Risk Management as Part of Laboratory Control and Stability Studies Out of Specification Results (II.7) To identify potential root causes and corrective actions during the investigation of out of specification results.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 33
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Quality Risk Management as Part of Laboratory Control and Stability Studies Out of Specification Results (II.7) To identify potential root causes and corrective actions during the investigation of out of specification results.
CB7K-DOM018-C68registry slot CB7K-DOM018-T07-G08PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

68. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 33

Narrow public claim

Quality Risk Management as Part of Supply Chain Control (II.9) Regarding product availability risks related to quality/manufacturing issues, product lifecycle oversight of the supply chain includes maintaining current knowledge of quality/manufacturing hazards and prioritizing efforts to manage such risks.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 33
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Quality Risk Management as Part of Supply Chain Control (II.9) Regarding product availability risks related to quality/manufacturing issues, product lifecycle oversight of the supply chain includes maintaining current knowledge of quality/manufacturing hazards and prioritizing efforts to manage such risks.
CB7K-DOM018-C69registry slot CB7K-DOM018-T07-G09PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

69. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 34

Narrow public claim

Manufacturing Facilities and Equipment To ensure that facility infrastructure and equipment are suitable and designed for robust manufacturing (this includes packaging and testing) (see Annex II.4); To establish facility and equipment maintenance programs that assure reliable facility and equipment performance; To ensure that the operational design of equipment is not vulnerable to human error; To obtain quality and efficiency gains through the utilization of digitalization, automation, isolation technology, and other innovations.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 34
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Manufacturing Facilities and Equipment To ensure that facility infrastructure and equipment are suitable and designed for robust manufacturing (this includes packaging and testing) (see Annex II.4); To establish facility and equipment maintenance programs that assure reliable facility and equipment performance; To ensure that the operational design of equipment is not vulnerable to human error; To obtain quality and efficiency gains through the utilization of digitalization, automation, isolation technology, and other innovations.
CB7K-DOM018-C70registry slot CB7K-DOM018-T07-G10PASSED: EXACT PRIMARY-SOURCE STATEMENT FOUND

70. FDA ICH Q9(R1) Quality Risk Management Guidance · PDF page 34

Narrow public claim

Supplier Oversight and Relationships To enhance review and monitoring activities (see section III.G (2.7) of ICH Q10) when substantial variability is identified in the quality and safety of supplied materials or in the services provided.

What this card proves

The exact quoted statement occurred in the named official PDF fetched on 2026-08-11, and the complete PDF matched the recorded SHA-256.

What this card does not prove

It does not independently establish the underlying model capability, safety, comparison, or real-world truth. This is a retrospective single-maintainer source-publication audit.

Primary source
FDA ICH Q9(R1) Quality Risk Management Guidance
Section locator
PDF page 34
Captured
2026-08-11
Source SHA-256
3e439cdcd02224f52ab889c2ffcf3c68e116024f000a8309a8d260aba242b8e1
Reproduction
Maintainer run only; no independent operator rerun is registered.
Repeat this exact check locally

Download the PDF to a local file, then run the committed verifier. A changed PDF is reported as drift rather than silently accepted.

python scripts/verify_primary_public_claim_group.py artifacts/cb7k_dom018_t07_primary_claims.json --source-file <local-raw-pdf>
Exact source quote
Supplier Oversight and Relationships To enhance review and monitoring activities (see section III.G (2.7) of ICH Q10) when substantial variability is identified in the quality and safety of supplied materials or in the services provided.